Skip to main content

Onex Partners and Co-Investors to Acquire AirSprint, Canada’s Leader in Fractional Jet Ownership

Founder, CEO and select shareholders to remain investors as AirSprint enters its next chapter of growth All amounts in U.S. dollars unless otherwise stated  TORONTO, June 25, 2026 (GLOBE NEWSWIRE) — Onex Partners (“Onex”) today announced that the Onex Partners Opportunities Fund, TriWest Capital Partners (“TriWest”) and certain other co-investors have agreed to acquire AirSprint Inc. (“AirSprint”), the largest fractional jet operator in Canada. AirSprint’s Founder & Chairman Judson Macor, President & CEO James Elian and certain of its current shareholders will remain investors following closing of the transaction. Headquartered in Calgary, Alberta, with offices in Toronto and Montréal, AirSprint operates the largest fractional fleet of private aircraft in Canada. AirSprint provides coast-to-coast access, enabling Fractional...

Continue reading

Form 8.5 (EPT/RI) – Pharos Energy Plc

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code” 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Pharos Energy Plc(c)        Name of the party to the offer with which exempt principal trader is connected: Ratio Petroleum Energy LP(d)        Date dealing undertaken: 24 June 2026(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases and salesClass of relevant...

Continue reading

Form 8.3 – [ANIMALCARE GROUP PLC – 24 06 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 24 06 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Western Union and Intermex Provide an Update on Pending Acquisition of Intermex

DENVER and MIAMI, June 24, 2026 (GLOBE NEWSWIRE) — The Western Union Company (“Western Union”) (NYSE: WU) and International Money Express, Inc. (“Intermex”) (NASDAQ: IMXI) today provided an update on the approval process and timeline for Western Union’s pending acquisition of Intermex. To date, money transmission regulators in 51 applicable U.S. states and territories and in all international jurisdictions have provided their approval of or non-objection to the acquisition, and approval or non-objection is currently pending from one U.S. state. Western Union and Intermex remain actively engaged in discussions with regulators, including the New York State Department of Financial Services, to obtain the final regulatory approval. Western Union and Intermex anticipate closing the transaction as soon as reasonably practicable upon...

Continue reading

Passage Bio and Remix Therapeutics Announce Merger Agreement

Combined company to operate as Remix Therapeutics and advance Remix’s pipeline of novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin Remix’s lead program, REM-422, is an orally available mRNA degrader targeting MYB, a historically undruggable transcription factor implicated across multiple cancers Concurrent oversubscribed $100 million private placement financing of Remix expected to fund combined company operations into 2028, supporting delivery of several clinical readouts for REM-422 in 2027 Companies to hold joint conference call on June 24, 2026 at 4:30 PM ET PHILADELPHIA and WATERTOWN, Mass., June 24, 2026 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG) (“Passage Bio”) and Remix Therapeutics, Inc. (“Remix”), a clinical-stage biotechnology company developing...

Continue reading

Riviera Partners Acquires Lateral Labs, Expanding Its AI and Machine Learning Talent Search and Placement Capabilities

Acquisition unites industry’s leading tech-focused executive search firm with pioneering AI-native recruiting organization San Francisco , June 24, 2026 (GLOBE NEWSWIRE) — San Francisco, CA — June 24, 2026 — Riviera Partners, the leading global executive search firm specializing in technology leadership, today announced the acquisition of Lateral Labs, a specialized recruiting firm serving top AI startups.   The acquisition comes as companies remain challenged to meet the demand of organizational AI readiness. Adding Lateral Labs positions Riviera Partners to help companies meet that challenge across the full arc of an AI company’s growth, offering executive and technical talent search from seed-stage startup through IPO.  Lateral Labs partners with some of the most demanding technical teams in AI, including Cursor, ElevenLabs,...

Continue reading

PRESS RELEASE: Bigben Interactive enters into exclusive negotiations with Modelabs with a view to the disposal of its subsidiary Bigben Connected

Lesquin, 24 June 2026, 6:00 PM Bigben Interactive enters into exclusive negotiations with Modelabs with a view to the disposal of its subsidiary Bigben ConnectedLesquin, June 24, 2026 – Bigben Interactive (ISIN FR0000074072) (the “Company”) announces that it has entered into exclusive negotiations with Modelabs, with a view to the disposal of the entire share capital of its subsidiary Bigben Connected (the “Transaction”).As part of the conciliation proceedings opened for the benefit of the Company by judgment of the Commercial Court of Lille Métropole dated March 4, 2026 (the “Conciliation Proceedings”), the Company has initiated a process to review strategic options with respect to its asset portfolio, with the aim of strengthening its financial structure on a long-term basis. It is in this context that the Company has selected...

Continue reading

Matic Secures Minority Investment From Primus Capital and Acquires Policygenius’ Property and Casualty Insurance Book

Portfolio acquisition and new capital investment fuel Matic’s next phase of growth Columbus, Ohio, June 24, 2026 (GLOBE NEWSWIRE) — Matic, a leading embedded insurance platform, today announced a strategic growth investment from Primus Capital alongside the acquisition of Policygenius’ property and casualty insurance portfolio, marking continued momentum in the company’s expansion. New Strategic Capital Partner Matic has received a minority investment from Primus Capital. The investment will help support Matic’s continued development of its proprietary insurance platform, expansion of embedded partnerships, and pursuit of inorganic growth opportunities. “We have known Primus for many years and are thrilled to join forces with a firm we deeply respect and that fully supports our vision to reimagine insurance distribution,”...

Continue reading

AMASS Brands Group Enters SAFE Investment in Afterdream, a Fast-Growing Hemp-Derived THC Beverage Brand

SAFE Investment Establishes Rights to at least a 15.67% Ownership Interest in Afterdream on a Fully Diluted Basis Positions AMASS Within a Category Generating Over $1.1 Billion in Annual U.S. Sales1 SANTA MARIA, Calif., June 24, 2026 (GLOBE NEWSWIRE) — AMASS Brands Group (NASDAQ: AMSS) (“AMASS” or “the Company”), a premium, multi-category beverage platform spanning non-alcohol, functional, and alcohol 2.0 products, today announced that it has entered into a Simple Agreement for Future Equity (SAFE) in Afterdream, representing the right to receive at least a 15.67% ownership interest in Afterdream on a fully diluted basis upon a future qualifying financing or liquidity event. The investment positions AMASS as a core investor in Afterdream, a rapidly growing hemp-derived THC beverage brand operating at the intersection of the non-alcoholic,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.